A549
|
IC50 |
|
Antitumour activity against human A549 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antitumour activity against human A549 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 31102934]
|
B16
|
IC50 |
|
Antitumour activity against mouse B16 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antitumour activity against mouse B16 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 31102934]
|
Cancer cell lines
|
GI50 |
|
Concentration required to inhibit the growth of HOP-6 human lung cancer cells by 50%
Concentration required to inhibit the growth of HOP-6 human lung cancer cells by 50%
|
[PMID: 16078843]
|
DU-145
|
GI50 |
1.2 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human DU145 cells at 96 hrs by WST1 assay
Antiproliferative activity against human DU145 cells at 96 hrs by WST1 assay
|
[PMID: 22247790]
|
DU-145
|
GI50 |
|
Antiproliferative activity against human DU145 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human DU145 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
DU-145
|
GI50 |
|
Antiproliferative activity against human DU145 cells after 96 hrs by WST1 assay
Antiproliferative activity against human DU145 cells after 96 hrs by WST1 assay
|
[PMID: 17696419]
|
DU-145
|
GI50 |
|
Concentration required to inhibit the growth of DU-145 human prostate cancer cells by 50%
Concentration required to inhibit the growth of DU-145 human prostate cancer cells by 50%
|
[PMID: 16078843]
|
ECa-109 cell line
|
IC50 |
|
Antitumour activity against human EC109 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antitumour activity against human EC109 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 31102934]
|
HCT-116
|
GI50 |
|
Antiproliferative activity against human HCT116 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human HCT116 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
HCT-116
|
GI50 |
|
Concentration required to inhibit the growth of HCT116 human colon cancer cells by 50%
Concentration required to inhibit the growth of HCT116 human colon cancer cells by 50%
|
[PMID: 16078843]
|
HEK-293T
|
IC50 |
4.6 μM
Compound: 2-methoxyestradiol
|
Cytotoxicity against HEK293T cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against HEK293T cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36455509]
|
HeLa
|
IC50 |
|
Antiproliferative activity against human HeLa cells expressing tubulin 3beta by sulforhodamine B assay
Antiproliferative activity against human HeLa cells expressing tubulin 3beta by sulforhodamine B assay
|
[PMID: 20973488]
|
HeLa
|
IC50 |
|
Antiproliferative activity against human HeLa cells by sulforhodamine B assay
Antiproliferative activity against human HeLa cells by sulforhodamine B assay
|
[PMID: 20973488]
|
HeLa
|
IC50 |
8.6 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36455509]
|
HepG2
|
IC50 |
11.03 μM
Compound: 2; 2-ME2
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 28810190]
|
HepG2
|
IC50 |
2.3 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36455509]
|
HL-60
|
IC50 |
0.9 μM
Compound: Table 3 R4C1
|
Cytotoxicity against vincristine-resistant human HL60 cells after 72 hrs MTS assay
Cytotoxicity against vincristine-resistant human HL60 cells after 72 hrs MTS assay
|
[PMID: 20411988]
|
HL-60
|
IC50 |
3.4 μM
Compound: Table 3 R4C1
|
Cytotoxicity against human HL60 cells after 72 hrs MTS assay
Cytotoxicity against human HL60 cells after 72 hrs MTS assay
|
[PMID: 20411988]
|
HOP-62
|
GI50 |
|
Antiproliferative activity against human HOP62 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human HOP62 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
HUVEC
|
IC50 |
0.68 μM
Compound: 2ME2, Panzem
|
Antiangiogenic activity against HUVEC assessed as growth inhibition after 48 hrs by WST1 assay
Antiangiogenic activity against HUVEC assessed as growth inhibition after 48 hrs by WST1 assay
|
[PMID: 19782564]
|
HUVEC
|
IC50 |
0.84 μM
Compound: 1, 2ME2
|
Antiproliferative activity against human HUVECs after 48 hrs
Antiproliferative activity against human HUVECs after 48 hrs
|
[PMID: 17910916]
|
HUVEC
|
IC50 |
|
Antiangiogenic activity against HUVECs by Brdu incorporation assay
Antiangiogenic activity against HUVECs by Brdu incorporation assay
|
[PMID: 19762246]
|
HUVEC
|
IC50 |
14.17 μM
Compound: 2; 2-ME2
|
Antiproliferative activity against HUVEC after 48 hrs by MTT assay
Antiproliferative activity against HUVEC after 48 hrs by MTT assay
|
[PMID: 28810190]
|
Ishikawa
|
IC50 |
8.96 μM
Compound: 2; 2-ME2
|
Antiproliferative activity against human Ishikawa cells after 48 hrs by MTT assay
Antiproliferative activity against human Ishikawa cells after 48 hrs by MTT assay
|
[PMID: 28810190]
|
K562
|
IC50 |
|
Anticancer activity against human K562 cells assessed as cell growth inhibition after 5 days by MTT assay
Anticancer activity against human K562 cells assessed as cell growth inhibition after 5 days by MTT assay
|
[PMID: 25108078]
|
MCF7
|
IC50 |
> 70 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36455509]
|
MCF7
|
IC50 |
0.842 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human MCF7 cells after 72 hrs by crystal violet biomass reduction assay
Antiproliferative activity against human MCF7 cells after 72 hrs by crystal violet biomass reduction assay
|
[PMID: 20334421]
|
MCF7
|
GI50 |
|
Inhibition of the growth of human breast cancer MCF-7 cells done for 2 hr at 37 degree C with compound
Inhibition of the growth of human breast cancer MCF-7 cells done for 2 hr at 37 degree C with compound
|
[PMID: 16078843]
|
MCF7
|
IC50 |
2.39 μM
Compound: 1 (2-MeOE2)
|
Anti-proliferative activity against MCF-7 human breast cancer cells was determined by using MCF-7 plate assay
Anti-proliferative activity against MCF-7 human breast cancer cells was determined by using MCF-7 plate assay
|
[PMID: 15149660]
|
MCF7
|
IC50 |
6.01 μM
Compound: 2; 2-ME2
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 28810190]
|
MDA-MB-231
|
IC50 |
0.79 μM
Compound: 2ME2, Panzem
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by WST1 assay
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by WST1 assay
|
[PMID: 19782564]
|
MDA-MB-231
|
GI50 |
|
Antiproliferative activity against human MDA-MB-231 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human MDA-MB-231 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
MDA-MB-231
|
GI50 |
|
Antiproliferative activity against human MDA-MB-231 cells after 96 hrs by WST1 assay
Antiproliferative activity against human MDA-MB-231 cells after 96 hrs by WST1 assay
|
[PMID: 17696419]
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs
|
[PMID: 17910916]
|
MDA-MB-435
|
GI50 |
|
Concentration required to inhibit the growth of MDA-MB-435 human breast cancer cells by 50%
Concentration required to inhibit the growth of MDA-MB-435 human breast cancer cells by 50%
|
[PMID: 16078843]
|
MDA-MB-435
|
IC50 |
|
Antiproliferative activity against human MDA-MB-435 cells by Brdu incorporation assay
Antiproliferative activity against human MDA-MB-435 cells by Brdu incorporation assay
|
[PMID: 19762246]
|
MGC-803
|
IC50 |
|
Antitumour activity against human MGC803 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antitumour activity against human MGC803 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 31102934]
|
OVCAR-3
|
GI50 |
|
Antiproliferative activity against human OVCAR-3 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human OVCAR-3 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
OVCAR-3
|
GI50 |
|
Concentration required to inhibit the growth of OVCAR-3 human ovarian cancer cells by 50%
Concentration required to inhibit the growth of OVCAR-3 human ovarian cancer cells by 50%
|
[PMID: 16078843]
|
OVCAR-3
|
IC50 |
|
Anticancer activity against human OVCAR3 cells assessed as cell growth inhibition after 5 days by MTT assay
Anticancer activity against human OVCAR3 cells assessed as cell growth inhibition after 5 days by MTT assay
|
[PMID: 25108078]
|
PC-3
|
IC50 |
12.31 μM
Compound: 2; 2-ME2
|
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 28810190]
|
PC-3
|
IC50 |
|
Antiproliferative activity against human PC3 cells by Brdu incorporation assay
Antiproliferative activity against human PC3 cells by Brdu incorporation assay
|
[PMID: 19762246]
|
PC-3
|
IC50 |
|
Cytotoxicity against human PC3 cells after 72 hrs by CellTiter one aqueous solution assay
Cytotoxicity against human PC3 cells after 72 hrs by CellTiter one aqueous solution assay
|
[PMID: 31195168]
|
SF-539
|
GI50 |
|
Antiproliferative activity against human SF539 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human SF539 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
SF-539
|
GI50 |
|
Concentration required to inhibit the growth of SF-539 human CNS cancer cells by 50%
Concentration required to inhibit the growth of SF-539 human CNS cancer cells by 50%
|
[PMID: 16078843]
|
SK-N-SH
|
IC50 |
|
Antitumour activity against human SK-N-SH cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antitumour activity against human SK-N-SH cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 31102934]
|
SK-OV-3
|
IC50 |
16.5 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36455509]
|
SK-OV-3
|
IC50 |
|
Antiproliferative activity against human SKOV3 cells expressing MDR1-6/6 by sulforhodamine B assay
Antiproliferative activity against human SKOV3 cells expressing MDR1-6/6 by sulforhodamine B assay
|
[PMID: 20973488]
|
SK-OV-3
|
IC50 |
|
Antiproliferative activity against human SKOV3 cells by sulforhodamine B assay
Antiproliferative activity against human SKOV3 cells by sulforhodamine B assay
|
[PMID: 20973488]
|
SMMC-7721
|
IC50 |
|
Antitumour activity against human SMMC7721 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antitumour activity against human SMMC7721 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 31102934]
|
SN12C
|
GI50 |
|
Antiproliferative activity against human SN12C cells after 96 hrs by WST-1 assay
Antiproliferative activity against human SN12C cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
SN12C
|
GI50 |
|
Concentration required to inhibit the growth of SN12C human renal cancer cells by 50%
Concentration required to inhibit the growth of SN12C human renal cancer cells by 50%
|
[PMID: 16078843]
|
T47D
|
IC50 |
25.2 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human T47D cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human T47D cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36455509]
|
U-87MG ATCC
|
IC50 |
|
Antiproliferative activity against human U87MG cells by Brdu incorporation assay
Antiproliferative activity against human U87MG cells by Brdu incorporation assay
|
[PMID: 19762246]
|
U-937
|
IC50 |
2.91 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human U937 cells by sulforhodamine B assay
Antiproliferative activity against human U937 cells by sulforhodamine B assay
|
[PMID: 20334421]
|
UACC-62
|
GI50 |
|
Antiproliferative activity against human UACC62 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human UACC62 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
UACC-62
|
GI50 |
|
Concentration required to inhibit the growth of UACC-62 human melanoma cells by 50%
Concentration required to inhibit the growth of UACC-62 human melanoma cells by 50%
|
[PMID: 16078843]
|